Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms:
VPC285785
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | VPC285785 is an orally active inhibitor of the SARS-CoV-2 main protease, with an IC50 of 0.8 μM and a Kd of 2.7 μM. It functionally inhibits the processing of viral polyprotein precursors by the viral main protease, necessary for viral replication. VPC285785 reduces viral load in liver, brain, and spleen tissues in MHV-infected mice. This compound is applicable for research on coronavirus infections. |
| In vitro | VPC285785 (10 μM) exhibits a low level of inhibition towards human cathepsin L (CatL), with an inhibition rate of only 15% observed at a concentration of 10 μM. |
| In vivo | Administration of VPC285785 (150 mg/kg; oral; once daily for 3 consecutive days) significantly reduces viral load in the liver, brain, and spleen of MHV-A59 infected mice, while maintaining their liver and kidney function. |
| Molecular Weight | 469.48 |
| Formula | C24H25F2N5O3 |
| Cas No. | 2759276-10-1 |
| Smiles | C(N[C@@H](C[C@H]1C(=O)NCC1)C#N)(=O)[C@@H]2[C@@]3([C@@](C3(C)C)(CN2C(=O)C4=CC=5C(N4)=CC(F)=CC5F)[H])[H] |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 µL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 µL Tween 80 and mix well until fully clarified.
3) Add 450 µL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.